home / stock / kmda / kmda news

KMDA News and Press, Kamada Ltd. From 11/04/25

Stock Information
Company Name: Kamada Ltd.
Stock Symbol: KMDA
Market: NASDAQ
Website: kamada.com
Menu
Get KMDA Alerts

News, Short Squeeze, Breakout and More Instantly...
KMDA - Kamada Announces First Patient Enrolled into an Investigator-Initiated Clinical Trial of CYTOGAM® to Prevent Cytomegalovirus in Kidney Transplantation

REHOVOT, Israel, and HOBOKEN, N.J. , Nov. 04, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced ...
KMDA - Kamada to Announce Third Quarter and Nine Months Ended September 30, 2025 Financial Results on November 10, 2025

REHOVOT, Israel and HOBOKEN, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, t...

KMDA - Kamada to Present at the Stifel 2025 Healthcare Conference

REHOVOT, Israel and Hoboken, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced th...

KMDA - My Top 5 Biotech Stocks Big Pharma Could Buy Next

2025-10-06 13:29:00 ET On September 17 , the Fed began cutting interest rates again, which historically preceded Big Pharma's increased activity in the M&A space.... Read the full article on Seeking Alpha For further details see: My Top 5 Biotech Stocks Big Pharm...
KMDA - Kamada to Participate in Upcoming September Investor Conferences

REHOVOT, Israel, and HOBOKEN, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced ...

KMDA - Kamada: Earnings Expansion Cycle With Embedded Margin Of Safety

2025-08-27 14:28:58 ET Investment Update Kamada Ltd. (NASDAQ: KMDA ) life sciences has continued to unlock additional opportunities for long-bias investors seeking low-speculative biotech names that sit at the left tail of distribution with non-US revenue exposures. Since my l...

KMDA - Kamada Ltd. (KMDA) Q2 2025 Earnings Call Transcript

2025-08-13 15:53:36 ET Kamada Ltd. (KMDA) Q2 2025 Earnings Conference Call August 13, 2025, 8:30 AM ET Company Participants Amir London - Chief Executive Officer Chaime Orlev - Chief Financial Officer Conference Call Participants Annabel Eva Samimy - Stif...
KMDA - Kamada GAAP EPS of $0.13 beats by $0.04, revenue of $44.75M misses by $1.78M

2025-08-13 07:03:51 ET More on Kamada Kamada Q2 2025 Earnings Preview Kamada confirms continuous business operations despite recent events in Middle East Seeking Alpha’s Quant Rating on Kamada Historical earnings data for Kamada Financial infor...

KMDA - Expected US Company Earnings on Wednesday, August 13th, 2025

Western Uranium & Vanadium Corp (WSTRF) is expected to report for Q2 2025 IceCure Medical Ltd. (ICCM) is expected to report $-0.06 for Q2 2025 TFF Pharmaceuticals Inc - Ordinary Shares (TFFP) is expected to report for quarter end 2025-06-30 Scientific Industries, Inc. (SCND) is ex...

KMDA - Kamada Reports Strong Second Quarter and First Half 2025 Financial Results with 11% Year-Over-Year 6-Month Top Line Growth and a 35% Increase in Profitability; Raises Full-Year Profitability Guidance

First Half 2025 Total Revenues were $88.8 Million, up 11% Year-over-Year ; Revenues for 2025 Second Quarter were $ 44 . 8 Million , up 5% Year-over-Year First Half 2025 Adjusted EBITDA of $22.5 Million, up 35% Year-over-Year and R ep...
Previous 10 Next 10